Physician profile
Michael M Stuart
NPI 1154524718
$1,508.06
in general payments reported to CMS, 2019-2025
18 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.77 · 2020: $164 · 2021: $148 · 2022: $265 · 2023: $265 · 2024: $247 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $783 · Education: $52.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $782.86 |
| Education | $52.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $474.36 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $181.13 | 2020-2025 | Dupixent |
| Stryker Corporation | $119.36 | 2020-2023 | Scopis Ent, Xpress Ent Dilation System |
| Acclarent, INC | $118.97 | 2019-2023 | Trudi Nav Cable, Relieva Spinplus, Acclarent Aera |
| Glaxosmithkline, LLC. | $99.92 | 2023-2025 | Nucala |
| Organogenesis INC. | $74.68 | 2024-2025 | Affinity |
| Sanofi-Aventis U.S. LLC | $52.99 | 2023 | |
| Aerin Medical INC. | $49.28 | 2025 | |
| Ethicon US, LLC | $47.75 | 2020 | |
| Phadia US INC. | $45.80 | 2022-2024 | Immunocap |
| Hikma Pharmaceuticals USA | $44.30 | 2023-2024 | Ryaltris |
| Minaris Medical America, INC. | $44.00 | 2021 | |
| Checkpoint Surgical, INC | $35.84 | 2019-2025 | Checkpoint Stimulators |
| Medtronic, INC. | $33.10 | 2022 | |
| Optinose US, INC. | $24.18 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pharming Healthcare, INC. | $23.18 | 2024 | Ruconest |
| Siemens Medical Solutions USA, INC. | $20.52 | 2020 | |
| Merck Sharp & Dohme LLC | $18.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.